Inpharma Weekly

, Volume 1323, Issue 1, pp 14–14 | Cite as

Rituximab + CHOP: first-line therapy in B-cell lymphoma

News item


England Journal Survival Duration Experience Disease Progression Median Survival Duration Chop Chemotherapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2002

Personalised recommendations